Metabolic impact of estrogen signalling through ERalpha and ERbeta

Journal of Steroid Biochemistry and Molecular Biology

Volumn 122, Issue 1-3, 2010, Pages 74-81

  Foryst Ludwig, Anna ^a   Kintscher, Ulrich ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Diabetes; Estrogen; Estrogen receptors; Glucose; Insulin; Metabolism; Obesity

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GLUCOSE;

ADIPOSE TISSUE; BODY FAT; BODY WEIGHT; CENTRAL NERVOUS SYSTEM; ENERGY BALANCE; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HUMAN; INFLAMMATION; INSULIN SENSITIVITY; LIPID METABOLISM; LIPOGENESIS; LIPOLYSIS; METABOLISM; NONHUMAN; PANCREAS ISLET BETA CELL; REVIEW; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SPECIES DIFFERENCE; WEIGHT REDUCTION; ANIMAL; ENERGY METABOLISM; LIVER; MOUSE; PHYSIOLOGY;

ADIPOSE TISSUE; ANIMALS; ENERGY METABOLISM; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; GLUCOSE; HUMANS; INSULIN-SECRETING CELLS; LIPID METABOLISM; LIVER; MICE; MUSCLE, SKELETAL; SIGNAL TRANSDUCTION;

EID: 77956455483     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2010.06.012     Document Type: Review

References (103)

1. Zimmet P., Alberti G., Kaufman F., Tajima N., Silink M., Arslanian S., Wong G., Bennett P., Shaw J., Caprio S. The metabolic syndrome in children and adolescents. Lancet 2007, 369(June (9579)):2059-2061.
2. Magliano D.J., Shaw J.E., Shortreed S.M., Nusselder W.J., Liew D., Barr E.L., Zimmet P.Z., Peeters A. Lifetime risk and projected population prevalence of diabetes. Diabetologia 2008, 51(December (12)):2179-2186.
3. Zimmet P., Magliano D., Matsuzawa Y., Alberti G., Shaw J. The metabolic syndrome: a global public health problem and a new definition. Journal of Atherosclerosis and Thrombosis 2005, 12(6):295-300.
4. Despres J.P., Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006, 444(December (7121)):881-887.
5. Cooke P.S., Naaz A. Role of estrogens in adipocyte development and function. Experimental Biology and Medicine (Maywood, NJ) 2004, 229(December (11)):1127-1135.
6. Cooke P.S., Heine P.A., Taylor J.A., Lubahn D.B. The role of estrogen and estrogen receptor-alpha in male adipose tissue. Molecular and Cellular Endocrinology 2001, 178(June (1-2)):147-154.
7. Bryzgalova G., Lundholm L., Portwood N., Gustafsson J.A., Khan A., Efendic S., Dahlman-Wright K. Mechanisms of antidiabetogenic and body weight-lowering effects of estrogen in high-fat diet-fed mice. American Journal of Physiology 2008, 295(October (4)):E904-E912.
8. Heine P.A., Taylor J.A., Iwamoto G.A., Lubahn D.B., Cooke P.S. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proceedings of the National Academy of Sciences of the United States of America 2000, 97(November (23)):12729-12734.
9. Naaz A., Zakroczymski M., Heine P., Taylor J., Saunders P., Lubahn D., Cooke P.S. Effect of ovariectomy on adipose tissue of mice in the absence of estrogen receptor alpha (ERalpha): a potential role for estrogen receptor beta (ERbeta). Hormone and Metabolic Research=Hormon-und Stoffwechselforschung=Hormones et metabolisme. 2002, 34(November-December (11-12)):758-763.
10. Bryzgalova G., Gao H., Ahren B., Zierath J.R., Galuska D., Steiler T.L., Dahlman-Wright K., Nilsson S., Gustafsson J.A., Efendic S., Khan A. Evidence that oestrogen receptor-alpha plays an important role in the regulation of glucose homeostasis in mice: insulin sensitivity in the liver. Diabetologia 2006, 49(March (3)):588-597.
11. Foryst-Ludwig A., Clemenz M., Hohmann S., Hartge M., Sprang C., Frost N., Krikov M., Bhanot S., Barros R., Morani A., Gustafsson J.A., Unger T., Kintscher U. Metabolic actions of estrogen receptor beta (ERbeta) are mediated by a negative cross-talk with PPARgamma. PLoS Genetics 2008, 4(June (6)):e1000108.
12. Misso M.L., Murata Y., Boon W.C., Jones M.E., Britt K.L., Simpson E.R. Cellular and molecular characterization of the adipose phenotype of the aromatase-deficient mouse. Endocrinology 2003, 144(April (4)):1474-1480.
13. Murata Y., Robertson K.M., Jones M.E., Simpson E.R. Effect of estrogen deficiency in the male: the ArKO mouse model. Molecular and Cellular Endocrinology 2002, 193(July (1-2)):7-12.
14. Carani C., Qin K., Simoni M., Faustini-Fustini M., Serpente S., Boyd J., Korach K.S., Simpson E.R. Effect of testosterone and estradiol in a man with aromatase deficiency. The New England Journal of Medicine 1997, 337(July (2)):91-95.
15. Louet J.F., LeMay C., Mauvais-Jarvis F. Antidiabetic actions of estrogen: insight from human and genetic mouse models. Current Atherosclerosis Reports 2004, (May (3)):180-185.
16. Margolis K.L., Bonds D.E., Rodabough R.J., Tinker L., Phillips L.S., Allen C., Bassford T., Burke G., Torrens J., Howard B.V. Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial. Diabetologia 2004, 47(July (7)):1175-1187.
17. Bonds D.E., Lasser N., Qi L., Brzyski R., Caan B., Heiss G., Limacher M.C., Liu J.H., Mason E., Oberman A., O'Sullivan M.J., Phillips L.S., Prineas R.J., Tinker L. The effect of conjugated equine oestrogen on diabetes incidence: the Women's Health Initiative randomised trial. Diabetologia 2006, 49(March (3)):459-468.
18. Crespo C.J., Smit E., Snelling A., Sempos C.T., Andersen R.E. Hormone replacement therapy and its relationship to lipid and glucose metabolism in diabetic and nondiabetic postmenopausal women: results from the Third National Health and Nutrition Examination Survey (NHANES III). Diabetes Care 2002, 25(October (10)):1675-1680.
19. Lonard D.M., Lanz R.B., O'Malley B.W. Nuclear receptor coregulators and human disease. Endocrine Reviews 2007, 28(August (5)):575-587.
20. Lonard D.M., O'Malley B.W. The expanding cosmos of nuclear receptor coactivators. Cell 2006, 125(May (3)):411-414.
21. Nilsson S., Gustafsson J.A. Biological role of estrogen and estrogen receptors. Critical Reviews in Biochemistry and Molecular Biology 2002, 37(1):1-28.
22. Osborne C.K., Schiff R. Estrogen-receptor biology: continuing progress and therapeutic implications. Journal of Clinical Oncology 2005, 23(March (8)):1616-1622.
23. Matthews J., Gustafsson J.A. Estrogen signaling: a subtle balance between ER alpha and ER beta. Molecular Interventions 2003, 3(August (5)):281-292.
24. Merchenthaler I., Lane M.V., Numan S., Dellovade T.L. Distribution of estrogen receptor alpha and beta in the mouse central nervous system: in vivo autoradiographic and immunocytochemical analyses. The Journal of Comparative Neurology 2004, 473(May (2)):270-291.
25. Couse J.F., Korach K.S. Estrogen receptor null mice: what have we learned and where will they lead us?. Endocrine Reviews 1999, 20(June (3)):358-417.
26. Dieudonne M.N., Leneveu M.C., Giudicelli Y., Pecquery R. Evidence for functional estrogen receptors alpha and beta in human adipose cells: regional specificities and regulation by estrogens. American Journal of Physiology Cell Physiology 2004, 286(March (3)):C655-661.
27. Sharma P.K., Thakur M.K. Expression of estrogen receptor (ER) alpha and beta in mouse cerebral cortex: effect of age, sex and gonadal steroids. Neurobiology of Aging 2006, (June (6)):880-887.
28. Batra G.S., Hainey L., Freemont A.J., Andrew G., Saunders P.T., Hoyland J.A., Braidman I.P. Evidence for cell-specific changes with age in expression of oestrogen receptor (ER) alpha and beta in bone fractures from men and women. The Journal of Pathology 2003, 200(May (1)):65-73.
29. Sakaguchi H., Fujimoto J., Aoki I., Tamaya T. Expression of estrogen receptor alpha and beta in myometrium of premenopausal and postmenopausal women. Steroids 2003, 68(January (1)):11-19.
30. Bonomo S.M., Rigamonti A.E., Giunta M., Galimberti D., Guaita A., Gagliano M.G., Muller E.E., Cella S.G. Menopausal transition: a possible risk factor for brain pathologic events. Neurobiology of Aging 2009, 30(January (1)):71-80.
31. Post W.S., Goldschmidt-Clermont P.J., Wilhide C.C., Heldman A.W., Sussman M.S., Ouyang P., Milliken E.E., Issa J.P. Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovascular Research 1999, 43(September (4)):985-991.
32. Wu C., Orozco C., Boyer J., Leglise M., Goodale J., Batalov S., Hodge C.L., Haase J., Janes J., Huss J.W., Su A.I. BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biology 2009, 10(11):R130.
33. Deroo B.J., Korach K.S. Estrogen receptors and human disease. The Journal of Clinical Investigation 2006, 116(March (3)):561-570.
34. Heldring N., Pike A., Andersson S., Matthews J., Cheng G., Hartman J., Tujague M., Strom A., Treuter E., Warner M., Gustafsson J.A. Estrogen receptors: how do they signal and what are their targets. Physiological Reviews 2007, 87(July (3)):905-931.
35. Delaunay F., Pettersson K., Tujague M., Gustafsson J.A. Functional differences between the amino-terminal domains of estrogen receptors alpha and beta. Molecular Pharmacology 2000, 58(September (3)):584-590.
36. Barkhem T., Nilsson S., Gustafsson J.A. Molecular mechanisms, physiological consequences and pharmacological implications of estrogen receptor action. American Journal of Pharmacogenomics 2004, 4(1):19-28.
37. Bulayeva N.N., Gametchu B., Watson C.S. Quantitative measurement of estrogen-induced ERK 1 and 2 activation via multiple membrane-initiated signaling pathways. Steroids 2004, 69(March (3)):181-192.
38. Cederroth C.R., Vinciguerra M., Gjinovci A., Kuhne F., Klein M., Cederroth M., Caille D., Suter M., Neumann D., James R.W., Doerge D.R., Wallimann T., Meda P., Foti M., Rohner-Jeanrenaud F., Vassalli J.D., Nef S. Dietary phytoestrogens activate AMP-activated protein kinase with improvement in lipid and glucose metabolism. Diabetes 2008, 57(May (5)):1176-1185.
39. Cederroth C.R., Vinciguerra M., Kuhne F., Madani R., Doerge D.R., Visser T.J., Foti M., Rohner-Jeanrenaud F., Vassalli J.D., Nef S. A phytoestrogen-rich diet increases energy expenditure and decreases adiposity in mice. Environmental Health Perspectives 2007, 115(October (10)):1467-1473.
40. Pedram A., Razandi M., Levin ER Nature of functional estrogen receptors at the plasma membrane. Molecular Endocrinology (Baltimore, MD) 2006, 20(September (9)):1996-2009.
41. Razandi M., Pedram A., Merchenthaler I., Greene G.L., Levin ER Plasma membrane estrogen receptors exist and functions as dimers. Molecular Endocrinology (Baltimore, MD) 2004, 18(December (12)):2854-2865.
42. Kim H.P., Lee J.Y., Jeong J.K., Bae S.W., Lee H.K., Jo I. Nongenomic stimulation of nitric oxide release by estrogen is mediated by estrogen receptor alpha localized in caveolae. Biochemical and Biophysical Research Communications 1999, 263(September (1)):257-262.
43. Carlezon W.A., Duman R.S., Nestler E.J. The many faces of CREB. Trends in Neurosciences 2005, 28(August (8)):436-445.
44. Prossnitz E.R., Arterburn J.B., Smith H.O., Oprea T.I., Sklar L.A., Hathaway H.J. Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Annual Review of Physiology 2008, 70:165-190.
45. Nadal A., Alonso-Magdalena P., Soriano S., Quesada I., Ropero A.B. The pancreatic beta-cell as a target of estrogens and xenoestrogens: implications for blood glucose homeostasis and diabetes. Molecular and Cellular Endocrinology 2009, 304(May (1-2)):63-68.
46. Nadal A., Alonso-Magdalena P., Soriano S., Ropero A.B., Quesada I. The role of oestrogens in the adaptation of islets to insulin resistance. The Journal of Physiology 2009, 587(November (Pt 21)):5031-5037.
47. Soria B., Quesada I., Ropero A.B., Pertusa J.A., Martin F., Nadal A. Novel players in pancreatic islet signaling: from membrane receptors to nuclear channels. Diabetes 2004, 53(February (Suppl. 1)):S86-91.
48. Nilsson S., Makela S., Treuter E., Tujague M., Thomsen J., Andersson G., Enmark E., Pettersson K., Warner M., Gustafsson J.A. Mechanisms of estrogen action. Physiological Reviews 2001, 81(October (4)):1535-1565.
49. Shang Y., Brown M Molecular determinants for the tissue specificity of SERMs. Science (New York, NY) 2002, 295(March (5564)):2465-2468.
50. Shang Y., Hu X., DiRenzo J., Lazar M.A., Brown M. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 2000, 103(December (6)):843-852.
51. Chang E.C., Charn T.H., Park S.H., Helferich W.G., Komm B., Katzenellenbogen J.A., Katzenellenbogen BS Estrogen Receptors alpha and beta as determinants of gene expression: influence of ligand, dose, and chromatin binding. Molecular Endocrinology (Baltimore, MD) 2008, 22(May (5)):1032-1043.
52. Okada M., Takezawa S., Mezaki Y., Yamaoka I., Takada I., Kitagawa H., Kato S. Switching of chromatin-remodelling complexes for oestrogen receptor-alpha. EMBO Reports 2008, 9(June (6)):563-568.
53. Wang X., Kilgore M.W. Signal cross-talk between estrogen receptor alpha and beta and the peroxisome proliferator-activated receptor gamma1 in MDA-MB-231 and MCF-7 breast cancer cells. Molecular and Cellular Endocrinology 2002, 194(August (1-2)):123-133.
54. Ropero A.B., Alonso-Magdalena P., Quesada I., Nadal A. The role of estrogen receptors in the control of energy and glucose homeostasis. Steroids 2008, 73(October (9-10)):874-879.
55. Laudenslager M.L., Wilkinson C.W., Carlisle H.J., Hammel H.T. Energy balance in ovariectomized rats with and without estrogen replacement. The American Journal of Physiology 1980, 238(May (5)):R400-405.
56. Saengsirisuwan V., Pongseeda S., Prasannarong M., Vichaiwong K., Toskulkao C. Modulation of insulin resistance in ovariectomized rats by endurance exercise training and estrogen replacement. Metabolism: Clinical and Experimental 2009, 58(January (1)):38-47.
57. Gao H., Bryzgalova G., Hedman E., Khan A., Efendic S., Gustafsson J.A., Dahlman-Wright K Long-term administration of estradiol decreases expression of hepatic lipogenic genes and improves insulin sensitivity in ob/ob mice: a possible mechanism is through direct regulation of signal transducer and activator of transcription 3. Molecular Endocrinology (Baltimore, MD) 2006, 20(June (6)):1287-1299.
58. Lundholm L., Bryzgalova G., Gao H., Portwood N., Falt S., Berndt K.D., Dicker A., Galuska D., Zierath J.R., Gustafsson J.A., Efendic S., Dahlman-Wright K., Khan A. The estrogen receptor {alpha}-selective agonist propyl pyrazole triol improves glucose tolerance in ob/ob mice; potential molecular mechanisms. The Journal of Endocrinology 2008, 199(November (2)):275-286.
59. Riant E., Waget A., Cogo H., Arnal J.F., Burcelin R., Gourdy P. Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice. Endocrinology 2009, 150(May (5)):2109-2117.
60. Jones M.E., Thorburn A.W., Britt K.L., Hewitt K.N., Misso M.L., Wreford N.G., Proietto J., Oz O.K., Leury B.J., Robertson K.M., Yao S., Simpson E.R., Aromatase-deficient (ArKO) mice accumulate excess adipose tissue. The Journal of Steroid Biochemistry and Molecular Biology 2001, 79(December (1-5)):3-9.
61. Jones M.E., Thorburn A.W., Britt K.L., Hewitt K.N., Wreford N.G., Proietto J., Oz O.K., Leury B.J., Robertson K.M., Yao S., Simpson E.R. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proceedings of the National Academy of Sciences of the United States of America 2000, 97(November (23)):12735-12740.
62. Takeda K., Toda K., Saibara T., Nakagawa M., Saika K., Onishi T., Sugiura T., Shizuta Y. Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency. The Journal of Endocrinology 2003, 176(February (2)):237-246.
63. Barros R.P., Machado U.F., Warner M., Gustafsson J.A. Muscle GLUT4 regulation by estrogen receptors ERbeta and ERalpha. Proceedings of the National Academy of Sciences of the United States of America 2006, 103(January (5)):1605-1608.
64. Ohlsson C., Hellberg N., Parini P., Vidal O., Bohlooly Y.M., Rudling M., Lindberg M.K., Warner M., Angelin B., Gustafsson J.A. Obesity and disturbed lipoprotein profile in estrogen receptor-alpha-deficient male mice. Biochemical and Biophysical Research Communications 2000, 278(November (3)):640-645.
65. Barros R.P., Machado U.F., Gustafsson J.A. Estrogen receptors: new players in diabetes mellitus. Trends in Molecular Medicine 2006, 12(September (9)):425-431.
66. Regitz-Zagrosek V., Lehmkuhl E., Weickert M.O. Gender differences in the metabolic syndrome and their role for cardiovascular disease. Clinical Research of Cardiology 2006, 95(March (3)):136-147.
67. Nuutila P., Knuuti M.J., Maki M., Laine H., Ruotsalainen U., Teras M., Haaparanta M., Solin O., Yki-Jarvinen H. Gender and insulin sensitivity in the heart and in skeletal muscles. Studies using positron emission tomography. Diabetes 1995, 44(January (1)):31-36.
68. Frias J.P., Macaraeg G.B., Ofrecio J., Yu J.G., Olefsky J.M., Kruszynska Y.T. Decreased susceptibility to fatty acid-induced peripheral tissue insulin resistance in women. Diabetes 2001, 50(June (6)):1344-1350.
69. Kuhl J., Hilding A., Ostenson C.G., Grill V., Efendic S., Bavenholm P. Characterisation of subjects with early abnormalities of glucose tolerance in the Stockholm Diabetes Prevention Programme: the impact of sex and type 2 diabetes heredity. Diabetologia 2005, 48(January (1)):35-40.
70. Macotela Y., Boucher J., Tran T.T., Kahn C.R. Sex and depot differences in adipocyte insulin sensitivity and glucose metabolism. Diabetes 2009, 58(April (4)):803-812.
71. D'Eon T.M., Souza S.C., Aronovitz M., Obin M.S., Fried S.K., Greenberg A.S. Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. The Journal of Biological Chemistry 2005, 280(October (43)):35983-35991.
72. Rogers N.H., Perfield J.W., Strissel K.J., Obin M.S., Greenberg A.S. Reduced energy expenditure and increased inflammation are early events in the development of ovariectomy-induced obesity. Endocrinology 2009, 150(May (5)):2161-2168.
73. Pedersen S.B., Kristensen K., Hermann P.A., Katzenellenbogen J.A., Richelsen B. Estrogen controls lipolysis by up-regulating alpha2A-adrenergic receptors directly in human adipose tissue through the estrogen receptor alpha. Implications for the female fat distribution. The Journal of Clinical Endocrinology and Metabolism 2004, 89(April (4)):1869-1878.
74. Hamosh M., Hamosh P. The effect of estrogen on the lipoprotein lipase activity of rat adipose tissue. The Journal of Clinical Investigation 1975, 55(May (5)):1132-1135.
75. Homma H., Kurachi H., Nishio Y., Takeda T., Yamamoto T., Adachi K., Morishige K., Ohmichi M., Matsuzawa Y., Murata Y. Estrogen suppresses transcription of lipoprotein lipase gene. Existence of a unique estrogen response element on the lipoprotein lipase promoter. The Journal of Biological Chemistry 2000, 275(April (15)):11404-11411.
76. Price T.M., O'Brien S.N., Welter B.H., George R., Anandjiwala J., Kilgore M. Estrogen regulation of adipose tissue lipoprotein lipase-possible mechanism of body fat distribution. American Journal of Obstetrics and Gynecology 1998, 178(January (Pt 1)):101-107.
77. Palin S.L., McTernan P.G., Anderson L.A., Sturdee D.W., Barnett A.H., Kumar S. 17Beta-estradiol and anti-estrogen ICI:compound 182,780 regulate expression of lipoprotein lipase and hormone-sensitive lipase in isolated subcutaneous abdominal adipocytes. Metabolism: Clinical and Experimental 2003, 52(April (4)):383-388.
78. Zimmermann R., Strauss J.G., Haemmerle G., Schoiswohl G., Birner-Gruenberger R., Riederer M., Lass A., Neuberger G., Eisenhaber F., Hermetter A., Zechner R Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science (New York, NY) 2004, 306(November (5700)):1383-1386.
79. Haemmerle G., Zimmermann R., Zechner R. Letting lipids go: hormone-sensitive lipase. Current Opinion in Lipidology 2003, 14(June (3)):289-297.
80. Ramis J.M., Salinas R., Garcia-Sanz J.M., Moreiro J., Proenza A.M., Llado I. Depot- and gender-related differences in the lipolytic pathway of adipose tissue from severely obese patients. Cellular Physiology and Biochemistry 2006, 17(3-4):173-180.
81. Wellen K.E., Hotamisligil G.S. Obesity-induced inflammatory changes in adipose tissue. The Journal of Clinical Investigation 2003, 112(December (12)):1785-1788.
82. Xu H., Barnes G.T., Yang Q., Tan G., Yang D., Chou C.J., Sole J., Nichols A., Ross J.S., Tartaglia L.A., Chen H. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. The Journal of Clinical Investigation 2003, 112(December (12)):1821-1830.
83. Kintscher U., Hartge M., Hess K., Foryst-Ludwig A., Clemenz M., Wabitsch M., Fischer-Posovszky P., Barth T.F., Dragun D., Skurk T., Hauner H., Bluher M., Unger T., Wolf A.M., Knippschild U., Hombach V., Marx N. T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arteriosclerosis, Thrombosis, and Vascular Biology 2008, 28(July (7)):1304-1310.
84. Arkan M.C., Hevener A.L., Greten F.R., Maeda S., Li Z.W., Long J.M., Wynshaw-Boris A., Poli G., Olefsky J., Karin M. IKK-beta links inflammation to obesity-induced insulin resistance. Nature Medicine 2005, 11(February (2)):191-198.
85. Tuncman G., Hirosumi J., Solinas G., Chang L., Karin M., Hotamisligil G.S. Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance. Proceedings of the National Academy of Sciences of the United States of America 2006, 103(July (28)):10741-10746.
86. Grimble R.F. Inflammatory status and insulin resistance. Current Opinion in Clinical Nutrition and Metabolic Care 2002, 5(September (5)):551-559.
87. Festa A., D'Agostino R., Howard G., Mykkanen L., Tracy R.P., Haffner S.M. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000, 102(July (1)):42-47.
88. Hundal R.S., Petersen K.F., Mayerson A.B., Randhawa P.S., Inzucchi S., Shoelson S.E., Shulman G.I. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. The Journal of Clinical Investigation 2002, 109(May (10)):1321-1326.
89. Yuan M., Konstantopoulos N., Lee J., Hansen L., Li Z.W., Karin M., Shoelson SE Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science (New York, NY) 2001, 293(August (5535)):1673-1677.
90. Barros R.P., Gabbi C., Morani A., Warner M., Gustafsson J.A. Participation of ERalpha and ERbeta in glucose homeostasis in skeletal muscle and white adipose tissue. American Journal of Physiology 2009, 297(July (1)):E124-133.
91. Breen D.M., Sanli T., Giacca A., Tsiani E. Stimulation of muscle cell glucose uptake by resveratrol through sirtuins and AMPK. Biochemical and Biophysical Research Communications 2008, 374(September (1)):117-122.
92. Deng J.Y., Hsieh P.S., Huang J.P., Lu L.S., Hung L.M. Activation of estrogen receptor is crucial for resveratrol-stimulating muscular glucose uptake via both insulin-dependent and -independent pathways. Diabetes 2008, 57(July (7)):1814-1823.
93. Zhao C., Dahlman-Wright K., Gustafsson J.A. Estrogen receptor beta: an overview and update. Nuclear Receptor Signaling 2008, 6:e003.
94. Alonso-Magdalena P., Ropero A.B., Carrera M.P., Cederroth C.R., Baquie M., Gauthier B.R., Nef S., Stefani E., Nadal A. Pancreatic insulin content regulation by the estrogen receptor ER alpha. PloS One 2008, 3(4):e2069.
95. Le May C., Chu K., Hu M., Ortega C.S., Simpson E.R., Korach K.S., Tsai M.J., Mauvais-Jarvis F. Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice. Proceedings of the National Academy of Sciences of the United States of America 2006, 103(June (24)):9232-9237.
96. Morton G.J., Cummings D.E., Baskin D.G., Barsh G.S., Schwartz M.W. Central nervous system control of food intake and body weight. Nature 2006, 443(September (7109)):289-295.
97. Vilberg T.R., Keesey R.E. Reduced energy expenditure after ventromedial hypothalamic lesions in female rats. The American Journal of Physiology 1984, 247(July (1 Pt 2)):R183-188.
98. Mitra S.W., Hoskin E., Yudkovitz J., Pear L., Wilkinson H.A., Hayashi S., Pfaff D.W., Ogawa S., Rohrer S.P., Schaeffer J.M., McEwen B.S., Alves S.E. Immunolocalization of estrogen receptor beta in the mouse brain: comparison with estrogen receptor alpha. Endocrinology 2003, 144(May (5)):2055-2067.
99. Geary N., Asarian L. Cyclic estradiol treatment normalizes body weight and test meal size in ovariectomized rats. Physiology & Behavior 1999, 67(August (1)):141-147.
100. Geary N., Asarian L., Korach K.S., Pfaff D.W., Ogawa S. Deficits in E2-dependent control of feeding, weight gain, and cholecystokinin satiation in ER-alpha null mice. Endocrinology 2001, 142(November (11)):4751-4757.
101. Musatov S., Chen W., Pfaff D.W., Mobbs C.V., Yang X.J., Clegg D.J., Kaplitt M.G., Ogawa S. Silencing of estrogen receptor alpha in the ventromedial nucleus of hypothalamus leads to metabolic syndrome. Proceedings of the National Academy of Sciences of the United States of America 2007, 104(February (7)):2501-2506.
102. Thammacharoen S., Geary N., Lutz T.A., Ogawa S., Asarian L. Divergent effects of estradiol and the estrogen receptor-alpha agonist PPT on eating and activation of PVN CRH neurons in ovariectomized rats and mice. Brain Research 2009, 1268(May (1)):88-96.
103. Pelletier G., Li S., Luu-The V., Labrie F. Oestrogenic regulation of pro-opiomelanocortin, neuropeptide Y and corticotrophin-releasing hormone mRNAs in mouse hypothalamus. Journal of Neuroendocrinology 2007, 19(June (6)):426-431.